Experienced in Squamous Cell Lung Carcinoma

Dr. Mahesh R. Kudrimoti

Radiation Oncology | Radiology
St Elizabeth Medical Center, Inc
1 Medical Village Dr, 
Edgewood, KY 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Experienced in Squamous Cell Lung Carcinoma
St Elizabeth Medical Center, Inc
1 Medical Village Dr, 
Edgewood, KY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Mahesh Kudrimoti is a Radiation Oncologist and a Radiologist in Edgewood, Kentucky. Dr. Kudrimoti is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Laryngeal Cancer, Throat Cancer, Fibrolamellar Carcinoma, Olfactory Neuroblastoma, and Pancreaticoduodenectomy. Dr. Kudrimoti is currently accepting new patients.

His clinical research consists of co-authoring 42 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Radiation Oncology
Radiology
Licenses
Radiology in KY
Hospital Affiliations
St Elizabeth Edgewood
St Elizabeth Dearborn Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Health Services
  • EPO
  • MANAGED MEDICAID PLAN
  • OTHER COMMERCIAL
Managed Medicaid
  • OTHER MANAGED MEDICAID
MDwise
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

ST ELIZABETH MEDICAL CENTER, INC
1 Medical Village Dr, Edgewood, KY 41017
Other Locations
ST ELIZABETH MEDICAL CENTER, INC
17525 Greendale Plaza Dr, Greendale, IN 47025

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Randomized Phase II/III Trial of Sentinel Lymph Node Biopsy Versus Elective Neck Dissection for Early-Stage Oral Cavity Cancer
Randomized Phase II/III Trial of Sentinel Lymph Node Biopsy Versus Elective Neck Dissection for Early-Stage Oral Cavity Cancer
Enrollment Status: Recruiting
Publish Date: January 14, 2026
Intervention Type: Procedure, Drug, Other
Study Phase: Phase 2/Phase 3
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
Enrollment Status: Active_not_recruiting
Publish Date: January 06, 2026
Intervention Type: Biological, Radiation
Study Drug: Cetuximab
Study Phase: Phase 3
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: October 31, 2025
Intervention Type: Other, Procedure, Drug, Biological, Radiation
Study Drugs: Cisplatin, Nivolumab
Study Phase: Phase 2/Phase 3
A Phase II-R and a Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients With Resected Head of Pancreas Adenocarcinoma
A Phase II-R and a Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients With Resected Head of Pancreas Adenocarcinoma
Enrollment Status: Completed
Publish Date: October 08, 2025
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Capecitabine, Chemotherapy, Erlotinib hydrochloride, Fluorouracil, Gemcitabine hydrochloride
Study Phase: Phase 3
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial of the Effects of GC4419 on Severe Oral Mucositis in Patients Receiving Cisplatin + Intensity-modulated Radiation Therapy (IMRT) for Locally Advanced Non-Metastatic Squamous Cell Carcinoma (SCC) of the Oral Cavity/Oropharynx
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial of the Effects of GC4419 on Severe Oral Mucositis in Patients Receiving Cisplatin + Intensity-modulated Radiation Therapy (IMRT) for Locally Advanced Non-Metastatic Squamous Cell Carcinoma (SCC) of the Oral Cavity/Oropharynx
Enrollment Status: Completed
Publish Date: September 20, 2021
Intervention Type: Radiation, Drug
Study Phase: Phase 2
Correlative Study of Nicotine Levels With Response Rates to Therapy Using Radiation Alone or in Combination With Chemotherapy in Head and Neck Cancer
Correlative Study of Nicotine Levels With Response Rates to Therapy Using Radiation Alone or in Combination With Chemotherapy in Head and Neck Cancer
Enrollment Status: Completed
Publish Date: July 14, 2021
View 5 Less Clinical Trials

43 Total Publications

A Two-Stage Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Ec-18 in Altering the Severity and Course of Oral Mucositis Secondary to Chemoradiation Therapy for Squamous Cell Cancers of the Head and Neck.
A Two-Stage Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Ec-18 in Altering the Severity and Course of Oral Mucositis Secondary to Chemoradiation Therapy for Squamous Cell Cancers of the Head and Neck.
Journal: Cancers
Published: March 30, 2025
Similar Doctors
Distinguished in Squamous Cell Lung Carcinoma
Dr. Anton E. Khouri
Radiation Oncology
Distinguished in Squamous Cell Lung Carcinoma
Dr. Anton E. Khouri
Radiation Oncology

Trihealth H LLC

379 Dixmyth Ave, 
Cincinnati, OH 
 (9.1 miles away)
513-246-7000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Anton Khouri is a Radiation Oncologist in Cincinnati, Ohio. Dr. Khouri is rated as a Distinguished provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Pleuropulmonary Blastoma, ALK-Positive Non-Small Cell Lung Cancer, Small Cell Lung Cancer (SCLC), and Squamous Cell Lung Carcinoma. Dr. Khouri is currently accepting new patients.

Advanced in Squamous Cell Lung Carcinoma
Dr. Bryan M. Rabatic
Radiation Oncology
Advanced in Squamous Cell Lung Carcinoma
Dr. Bryan M. Rabatic
Radiation Oncology

Trihealth H LLC

8240 Northcreek Dr, 
Cincinnati, OH 
 (16.8 miles away)
513-246-7000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Bryan Rabatic is a Radiation Oncologist in Cincinnati, Ohio. Dr. Rabatic is rated as an Advanced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Merkel Cell Carcinoma, Squamous Cell Lung Carcinoma, and Small Cell Lung Cancer (SCLC). Dr. Rabatic is currently accepting new patients.

Advanced in Squamous Cell Lung Carcinoma
Dr. Timothy D. Struve
Radiation Oncology
Advanced in Squamous Cell Lung Carcinoma
Dr. Timothy D. Struve
Radiation Oncology

University Of Cincinnati Physicians Company LLC

7710 Discovery Dr, 
West Chester, OH 
 (26.2 miles away)
513-475-7777
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Timothy Struve is a Radiation Oncologist in West Chester, Ohio. Dr. Struve is rated as a Distinguished provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Metastatic Brain Tumor, and Prostate Cancer. Dr. Struve is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kudrimoti's expertise for a condition
ConditionClose
    View All 13 Advanced Conditions
    View All 62 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile